Possibia

443

Last Update Posted: 2005-06-24

Recruiting has ended

All Genders

accepted

25 Years-60 Years

Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Ondansetron Treatment for Alcoholism

The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to treatment. Individuals will be "typed" into early onset and late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient treatment program.

Eligibility

Relevant conditions:

Alcoholism

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov